A detailed history of Core Cap Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 20,183 shares of MRK stock, worth $2.01 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
20,183
Previous 19,721 2.34%
Holding current value
$2.01 Million
Previous $2.44 Million 6.15%
% of portfolio
0.11%
Previous 0.27%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$111.15 - $128.97 $51,351 - $59,584
462 Added 2.34%
20,183 $2.29 Million
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $1.5 Million - $1.61 Million
12,134 Added 159.93%
19,721 $2.44 Million
Q1 2024

Aug 08, 2024

SELL
$113.24 - $131.95 $1.35 Million - $1.58 Million
-11,947 Reduced 60.58%
7,774 $1.03 Million
Q4 2023

Jan 12, 2024

SELL
$100.18 - $109.02 $1.41 Million - $1.53 Million
-14,051 Reduced 64.94%
7,587 $827,000
Q3 2023

Jan 12, 2024

SELL
$102.95 - $114.33 $915,431 - $1.02 Million
-8,892 Reduced 29.13%
21,638 $2.23 Million
Q2 2023

Jan 12, 2024

SELL
$108.61 - $118.38 $791,766 - $862,990
-7,290 Reduced 19.28%
30,530 $3.52 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $34,976 - $44,844
400 Added 1.07%
37,820 $4.2 Million
Q3 2022

Feb 10, 2023

BUY
$84.53 - $94.96 $2.66 Million - $2.99 Million
31,492 Added 531.24%
37,420 $3.22 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $43,080 - $48,834
-516 Reduced 8.01%
5,928 $540,000
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $6,321 - $7,086
86 Added 1.35%
6,444 $529,000
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $459,556 - $575,653
6,358 New
6,358 $487,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.